Managing cancer is already a heavy burden, but it becomes even more complex when a patient also lives with fibromyalgia. This condition can significantly amplify how the body perceives pain. When these two conditions exist together, patients often experience a much heavier load of symptoms and a lower quality of life.
Research involving 11 studies shows that having fibromyalgia does not increase the risk of developing cancer. However, it does make managing the side effects of cancer treatment harder. Specifically, patients with certain types of chronic pain features were more likely to stop their cancer treatments early, especially hormone-based therapies.
Because the evidence is still limited and some studies had a high risk of bias, doctors need more high-quality data to create perfect management plans. For now, it highlights why recognizing these overlapping conditions is vital for helping patients stay on their treatment paths.
Common questions
Does having fibromyalgia increase the risk of getting cancer?
No, the research shows that having fibromyalgia does not increase a person's risk of developing cancer. While it makes managing symptoms and treatment much harder, it does not change the underlying risk of the cancer itself.
How does fibromyalgia affect cancer treatment?
Fibromyalgia can lead to a higher burden of symptoms and lower quality of life for patients. It also makes it harder to stick to treatment plans. Specifically, certain pain features associated with fibromyalgia were linked to the premature stopping of cancer treatments, especially endocrine therapies.
Why is it harder for these patients to manage pain?
Fibromyalgia contributes significantly to pain amplification. This means the body's way of processing pain signals becomes more intense. When combined with cancer, this makes the overall symptom burden much heavier and can make it difficult for patients to tolerate their medications.
